CHICAGO — October 6, 2026 — AIRS Medical is pleased to announce the creation of its Clinical Advisory Board, a new advisory body that will provide clinical and strategic perspective to the company’s executive leadership as artificial intelligence continues to reshape medical imaging.
The Clinical Advisory Board will advise AIRS Medical on the long-term clinical and technology trends shaping MRI, including quantitative imaging, longitudinal assessment, clinical AI, workflow innovation, and the growing need for greater consistency across increasingly complex imaging environments. The Board will provide an external perspective as AIRS Medical advances its strategy and explores the next generation of AI-powered medical imaging.
Ann K. Jay, MD, is a nationally recognized neuroradiologist, educator, and academic leader with deep expertise in head and neck and skull base imaging. Her career has spanned advanced clinical practice, neuroradiology leadership, residency and medical school education, and national radiology organizations. She previously served as Chief of the Division of Neuroradiology, Director of Head and Neck Imaging, Vice Chair of Education, and Diagnostic Radiology Residency Program Director at MedStar Georgetown University Hospital, and will join Columbia University as Professor of Radiology and Director of Head and Neck Imaging in January 2027. Dr. Jay has also held national leadership roles with the American College of Radiology, Association of Academic Radiology, American Society of Head and Neck Radiology, and American Board of Radiology. This combination of clinical expertise, academic leadership, and physician education gives her a valuable perspective on how emerging imaging technologies can be translated into meaningful, practical advances in radiology practice.
Gregory J. Moore, MD, PhD, is a physician-scientist, neuroradiologist, engineer, and healthcare technology executive whose career spans clinical medicine, imaging science, artificial intelligence, cloud computing, and enterprise healthcare transformation. He has held senior leadership roles at Microsoft, Google Cloud, Geisinger Health System, and Gates Ventures, working at the intersection of healthcare, technology, and AI. Across these roles, he has helped shape the development and adoption of advanced technologies in healthcare, with a particular focus on translating emerging capabilities in AI, data, and cloud infrastructure into solutions that can operate at scale within complex clinical environments. His background as both a practicing neuroradiologist and technology leader brings a rare combination of clinical, technical, and enterprise perspective to the Advisory Board.
Additional Clinical Advisory Board members are expected to be announced shortly as the Board expands.
Jina Park, Chief Strategy Officer at AIRS Medical, commented: “MRI is entering a new era—one that is increasingly quantitative, longitudinal and AI-enabled. As we look ahead, we want experienced clinical and technology leaders challenging our thinking, helping us identify the most important unmet needs, and ensuring innovation translates into meaningful clinical value. Ann and Greg bring exceptional and complementary perspectives, and we are delighted to welcome them as founding members of our Clinical Advisory Board.”
Jason Park, CEO of AIRS Medical, added: “AI will transform medical imaging only as fast as clinicians trust it, and that trust is earned through clinical rigor. With SwiftMR now in use at more than 1,700 healthcare institutions worldwide, that responsibility has never been larger. Ann and Greg have spent their careers where medicine, science and technology meet, and their counsel will help ensure that what we build next is not just technically impressive, but clinically indispensable.”
About AIRS Medical
AIRS Medical is a global AI medical imaging company transforming MRI through deep learning. Its solutions, SwiftMR® and SwiftSight®, are deployed at leading health systems and imaging networks worldwide. SwiftMR® is FDA-cleared, CE-marked under MDR, and approved by regulatory authorities including Korea’s MFDS and Japan’s PMDA. AIRS Medical solutions are used by healthcare providers across more than 40 countries.
Learn more at airsmed.com.
Media Contact
Cynthia Ruffino
Vice President, Marketing
media@airsmed.com